Table of Content

1 Rare Disease Genetic Testing Market Introduction and Overview
1.1 Rare Disease Genetic Testing Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Rare Disease Genetic Testing Revenue and Market Share by Manufacturer
2.2 Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
2.3 Rare Disease Genetic Testing Market Competitive Situation and Trends
2.3.1 Rare Disease Genetic Testing Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Rare Disease Genetic Testing Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Rare Disease Genetic Testing Market Share by Type 2018 VS 2022
3.2 Global Rare Disease Genetic Testing Revenue and Market Share by Type
4 Global Rare Disease Genetic Testing Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Rare Disease Genetic Testing Market Share by Application 2018 VS 2022
4.2 Global Rare Disease Genetic Testing Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Rare Disease Genetic Testing Market Size (2018-2023)
5.2 Rare Disease Genetic Testing Growth Trends Analysis by Regions
5.2.1 Rare Disease Genetic Testing Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Quest Diagnostics Incorporated (U.S.)
6.1.1 Quest Diagnostics Incorporated (U.S.) Company Profile
6.1.2 Rare Disease Genetic Testing Product Overview
6.1.3 Quest Diagnostics Incorporated (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.1.4 Quest Diagnostics Incorporated (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2 Centogene N.V. (Germany)
6.2.1 Centogene N.V. (Germany) Company Profile
6.2.2 Rare Disease Genetic Testing Product Overview
6.2.3 Centogene N.V. (Germany) Rare Disease Genetic Testing Market Performance (2018-2023)
6.2.4 Centogene N.V. (Germany) Business Overview
6.2.5 SWOT Analysis
6.3 Strand Life Sciences (Bengaluru)
6.3.1 Strand Life Sciences (Bengaluru) Company Profile
6.3.2 Rare Disease Genetic Testing Product Overview
6.3.3 Strand Life Sciences (Bengaluru) Rare Disease Genetic Testing Market Performance (2018-2023)
6.3.4 Strand Life Sciences (Bengaluru) Business Overview
6.3.5 SWOT Analysis
6.4 Ambry Genetics (U.S.)
6.4.1 Ambry Genetics (U.S.) Company Profile
6.4.2 Rare Disease Genetic Testing Product Overview
6.4.3 Ambry Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.4.4 Ambry Genetics (U.S.) Business Overview
6.4.5 SWOT Analysis
6.5 PerkinElmer, Inc. (U.S.)
6.5.1 PerkinElmer, Inc. (U.S.) Company Profile
6.5.2 Rare Disease Genetic Testing Product Overview
6.5.3 PerkinElmer, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.5.4 PerkinElmer, Inc. (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6 Macrogen, Inc. (South Korea)
6.6.1 Macrogen, Inc. (South Korea) Company Profile
6.6.2 Rare Disease Genetic Testing Product Overview
6.6.3 Macrogen, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.6.4 Macrogen, Inc. (South Korea) Business Overview
6.6.5 SWOT Analysis
6.7 Baylor Genetics (U.S.)
6.7.1 Baylor Genetics (U.S.) Company Profile
6.7.2 Rare Disease Genetic Testing Product Overview
6.7.3 Baylor Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.7.4 Baylor Genetics (U.S.) Business Overview
6.7.5 SWOT Analysis
6.8 HNL Lab Medicine (U.S.)
6.8.1 HNL Lab Medicine (U.S.) Company Profile
6.8.2 Rare Disease Genetic Testing Product Overview
6.8.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.8.4 HNL Lab Medicine (U.S.) Business Overview
6.8.5 SWOT Analysis
6.9 Preventiongenetics (U.S.)
6.9.1 Preventiongenetics (U.S.) Company Profile
6.9.2 Rare Disease Genetic Testing Product Overview
6.9.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.9.4 Preventiongenetics (U.S.) Business Overview
6.9.5 SWOT Analysis
6.10 3billion, Inc. (South Korea)
6.10.1 3billion, Inc. (South Korea) Company Profile
6.10.2 Rare Disease Genetic Testing Product Overview
6.10.3 3billion, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.10.4 3billion, Inc. (South Korea) Business Overview
6.10.5 SWOT Analysis
6.11 Arup Laboratories (U.S.)
6.11.1 Arup Laboratories (U.S.) Company Profile
6.11.2 Rare Disease Genetic Testing Product Overview
6.11.3 Arup Laboratories (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.11.4 Arup Laboratories (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12 HNL Lab Medicine (U.S.)
6.12.1 HNL Lab Medicine (U.S.) Company Profile
6.12.2 Rare Disease Genetic Testing Product Overview
6.12.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.12.4 HNL Lab Medicine (U.S.) Business Overview
6.12.5 SWOT Analysis
6.13 Preventiongenetics (U.S.)
6.13.1 Preventiongenetics (U.S.) Company Profile
6.13.2 Rare Disease Genetic Testing Product Overview
6.13.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.13.4 Preventiongenetics (U.S.) Business Overview
6.13.5 SWOT Analysis
6.14 Invitae Corporation (U.S.)
6.14.1 Invitae Corporation (U.S.) Company Profile
6.14.2 Rare Disease Genetic Testing Product Overview
6.14.3 Invitae Corporation (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.14.4 Invitae Corporation (U.S.) Business Overview
6.14.5 SWOT Analysis
6.15 Eurofins Scientific (Luxembourg)
6.15.1 Eurofins Scientific (Luxembourg) Company Profile
6.15.2 Rare Disease Genetic Testing Product Overview
6.15.3 Eurofins Scientific (Luxembourg) Rare Disease Genetic Testing Market Performance (2018-2023)
6.15.4 Eurofins Scientific (Luxembourg) Business Overview
6.15.5 SWOT Analysis
6.16 Strand Life Sciences (India)
6.16.1 Strand Life Sciences (India) Company Profile
6.16.2 Rare Disease Genetic Testing Product Overview
6.16.3 Strand Life Sciences (India) Rare Disease Genetic Testing Market Performance (2018-2023)
6.16.4 Strand Life Sciences (India) Business Overview
6.16.5 SWOT Analysis
6.17 Realm IDX, Inc. (China)
6.17.1 Realm IDX, Inc. (China) Company Profile
6.17.2 Rare Disease Genetic Testing Product Overview
6.17.3 Realm IDX, Inc. (China) Rare Disease Genetic Testing Market Performance (2018-2023)
6.17.4 Realm IDX, Inc. (China) Business Overview
6.17.5 SWOT Analysis
6.18 Myriad Genetics, Inc. (U.S.)
6.18.1 Myriad Genetics, Inc. (U.S.) Company Profile
6.18.2 Rare Disease Genetic Testing Product Overview
6.18.3 Myriad Genetics, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.18.4 Myriad Genetics, Inc. (U.S.) Business Overview
6.18.5 SWOT Analysis
6.19 Laboratory Corporation of America Holdings (U.S.)
6.19.1 Laboratory Corporation of America Holdings (U.S.) Company Profile
6.19.2 Rare Disease Genetic Testing Product Overview
6.19.3 Laboratory Corporation of America Holdings (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.19.4 Laboratory Corporation of America Holdings (U.S.) Business Overview
6.19.5 SWOT Analysis
6.20 Opko Health, Inc. (U.S.)
6.20.1 Opko Health, Inc. (U.S.) Company Profile
6.20.2 Rare Disease Genetic Testing Product Overview
6.20.3 Opko Health, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.20.4 Opko Health, Inc. (U.S.) Business Overview
6.20.5 SWOT Analysis
7 Rare Disease Genetic Testing Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Rare Disease Genetic Testing Industrial Chain Analysis
8 Rare Disease Genetic Testing Industry Dynamic Analysis
8.1 Rare Disease Genetic Testing Market Trends Analysis
8.2 Rare Disease Genetic Testing Market Drivers Analysis
8.3 Rare Disease Genetic Testing Market Challenges Analysis
8.4 Rare Disease Genetic Testing Market Restraints Analysis
9 Global Rare Disease Genetic Testing Forecast Market Analysis by Type & Application
9.1 Global Rare Disease Genetic Testing Revenue Market Forecast by Type (2023-2029)
9.2 Rare Disease Genetic Testing Revenue Market Forecast by Application (2023-2029)
10 Global Rare Disease Genetic Testing Forecast Market Analysis by Region
10.1 Rare Disease Genetic Testing Revenue Market Forecast by Region (2023-2029)
10.2 North America Rare Disease Genetic Testing Forecast Market Analysis
10.3 EMEA Rare Disease Genetic Testing Forecast Market Analysis
10.4 China Rare Disease Genetic Testing Forecast Market Analysis
10.5 Asia-Pacific Rare Disease Genetic Testing Forecast Market Analysis
10.6 Latin America Rare Disease Genetic Testing Forecast Market Analysis
11 Research Findings and Conclusion